FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump’s Labor Department takes another hit as inspector general accused of abusing role

WATCH: America250 backdrop topples near Shapiro, Revolutionary War reenactors

Navy scraps Biden-era submarine contract as overhaul costs surge toward $3B

Unfortunate Video: Mamdani Thought Walking Through NYC Was a Great Photo Op, Then People Noticed What Was Behind Him

Report: Roger Stone Stepped in and ‘Saved’ Tulsi Gabbard from Being Fired by Trump

Nation’s second-largest school district targeted by Trump over secretive trans policy

Video: Hunter Biden Hits New Rock Bottom, Agrees to Insane Cage Match Against Don Jr., Eric Trump

BREAKING IMPEACHMENT NEWS: Hearings on Tim Walz, Keith Ellison Impeachment to Begin Next Week

Artemis II crew closes in on Earth as mission ends with Pacific splashdown and more top headlines

Midwest nasty: ‘Hoosier nice’ gets swamped in Trump White House’s redistricting revenge tour against Indiana Republicans

Sanford bets he can withstand likely Trump campaign jabs

Progressives in Washington, California, and Hawaii want to squeeze the wealthy

Rep Randy Fine joins House Freedom Caucus: ‘Strongest group of conservative patriots in Congress’

American couple’s Bahamas dinghy was ill-equipped for conditions night of wife’s disappearance: friend

DoorDash data offers snapshot of economy voters are feeling ahead of midterms

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”